Dr. Harriet Walter is an associate professor of Medical Oncology and an honorary consultant medical oncologist. She is the co-lead of the Leicester Experimental Cancer Medicines Centre and Director of the Hope Cancer Trials Centre. She is the Phase I lead in oncology at University Hospitals of Leicester with a growing trials portfolio. Her translational laboratory interests focus on precision medicines in B cell malignancies, including bispecific antibodies. Dr. Harriet Walter studied Medicine at the University of Birmingham, graduating with honours. She undertook her early postgraduate training at the West Midlands and Oxford Deanery prior to commencing speciality training in Medical Oncology in the East Midlands. During her training, she undertook a PhD at the Ernest and Helen Scott Haematological Research Institute at the University of Leicester under the supervision of Professor Martin Dyer. Dr Walter’s research interests are in therapeutic drug development, the design and delivery of early phase clinical trials, and the development and assessment of novel therapies in B cell malignancies. She works as a medical advisor for the Centre for Drug Development at Cancer Research, UK.
